Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arkema S.A. stock logo
ARKAY
Arkema
$105.64
$103.79
$85.58
$114.15
$7.93B1.353,548 shs732 shs
Burberry Group plc stock logo
BURBY
Burberry Group
$15.14
+2.6%
$15.47
$14.15
$32.81
$5.43B1.22100,241 shs45,474 shs
CapitaLand Limited stock logo
CLLDY
CapitaLand
$6.21
+3.4%
$6.21
$3.65
$6.31
$16.16B1.0710,943 shs3,800 shs
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$24.50
+9.7%
$23.64
$21.28
$27.15
$5.40B0.5159 shs207 shs
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
$40.11
+12.9%
$38.59
$32.60
$50.30
N/A0.42121 shs1,191 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arkema S.A. stock logo
ARKAY
Arkema
0.00%+2.37%-3.96%-1.38%+8.39%
Burberry Group plc stock logo
BURBY
Burberry Group
+2.61%+2.89%-0.75%-8.38%-53.59%
CapitaLand Limited stock logo
CLLDY
CapitaLand
0.00%0.00%0.00%0.00%0.00%
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.00%0.00%-7.92%-7.57%-2.44%
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
0.00%-0.59%-8.40%-6.69%-27.45%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arkema S.A. stock logo
ARKAY
Arkema
N/AN/AN/AN/AN/AN/AN/AN/A
Burberry Group plc stock logo
BURBY
Burberry Group
0.1565 of 5 stars
0.03.01.70.00.60.00.6
CapitaLand Limited stock logo
CLLDY
CapitaLand
N/AN/AN/AN/AN/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arkema S.A. stock logo
ARKAY
Arkema
3.00
BuyN/AN/A
Burberry Group plc stock logo
BURBY
Burberry Group
1.67
ReduceN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
N/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
2.00
HoldN/AN/A
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arkema S.A. stock logo
ARKAY
Arkema
$10.30B0.77$26.34 per share4.01$103.04 per share1.03
Burberry Group plc stock logo
BURBY
Burberry Group
$3.73B1.46$2.68 per share5.65$4.90 per share3.09
CapitaLand Limited stock logo
CLLDY
CapitaLand
$4.74B3.41N/AN/A$13.31 per share0.47
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$2.88B1.88$3.65 per share6.71$10.03 per share2.44
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
$2.54BN/A$3.66 per share10.95$19.63 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arkema S.A. stock logo
ARKAY
Arkema
$452.36M$5.8018.219.970.464.40%8.92%4.76%5/10/2024 (Estimated)
Burberry Group plc stock logo
BURBY
Burberry Group
$590.60MN/A0.0015.44N/AN/AN/AN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
-$1.14BN/A0.00N/AN/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$190MN/A0.0011.19N/AN/AN/AN/AN/A
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
$364.56M$1.7323.1818.74N/A8.43%11.29%8.91%N/A

Latest ARKAY, BURBY, CLLDY, SQNXF, and HKMPF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/29/202412/31/2023
Arkema S.A. stock logo
ARKAY
Arkema
$1.87$1.54-$0.33$2.79$2.44 billion$2.39 billion
2/5/2024Q3 2024
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/A$0.57+$0.57$0.57N/A$579.45 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arkema S.A. stock logo
ARKAY
Arkema
$3.102.93%N/A53.45%N/A
Burberry Group plc stock logo
BURBY
Burberry Group
$0.442.91%N/AN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
$0.121.93%N/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.943.84%N/AN/AN/A
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/AN/AN/AN/AN/A

Latest ARKAY, BURBY, CLLDY, SQNXF, and HKMPF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2024
Arkema S.A. stock logo
ARKAY
Arkema
$3.73635/15/20245/16/20246/5/2024
3/6/2024
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.473/20/20243/22/20245/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arkema S.A. stock logo
ARKAY
Arkema
0.40
2.25
1.64
Burberry Group plc stock logo
BURBY
Burberry Group
0.27
1.56
1.06
CapitaLand Limited stock logo
CLLDY
CapitaLand
0.79
0.95
0.95
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.47
1.57
0.90
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/A
4.73
4.64

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Arkema S.A. stock logo
ARKAY
Arkema
N/A
Burberry Group plc stock logo
BURBY
Burberry Group
10.31%
CapitaLand Limited stock logo
CLLDY
CapitaLand
N/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/A
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Arkema S.A. stock logo
ARKAY
Arkema
21,10075.04 millionN/ANot Optionable
Burberry Group plc stock logo
BURBY
Burberry Group
9,201358.58 millionN/ANot Optionable
CapitaLand Limited stock logo
CLLDY
CapitaLand
10,4732.60 billionN/ANot Optionable
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
8,800220.23 millionN/ANot Optionable
Square Enix Holdings Co., Ltd. stock logo
SQNXF
Square Enix
4,712N/AN/ANot Optionable

ARKAY, BURBY, CLLDY, SQNXF, and HKMPF Headlines

SourceHeadline
Square Enix Café Gets Limited Edition Sephiroth Bring Arts FigureSquare Enix Café Gets Limited Edition Sephiroth Bring Arts Figure
siliconera.com - May 3 at 1:26 AM
Square Enix Holdings Co LtdSquare Enix Holdings Co Ltd
morningstar.com - May 2 at 8:25 PM
Square Enix announces £112m in "content abandonment losses" as it seeks to be more selectiveSquare Enix announces £112m in "content abandonment losses" as it seeks to be more selective
rockpapershotgun.com - May 1 at 7:03 PM
Square Enix to be more selective as it loses £112 million in cancelled gamesSquare Enix to be more 'selective' as it loses £112 million in cancelled games
msn.com - May 1 at 2:03 PM
Square Enix announces its tanked $140 million in losses due to content abandonment, though theres no clue as to whats been dropped—and whereSquare Enix announces it's tanked $140 million in losses due to 'content abandonment', though there's no clue as to what's been dropped—and where
pcgamer.com - May 1 at 2:03 PM
Rumor: Square Enix Has Changed The Studio Making Dragon Quest XIIRumor: Square Enix Has Changed The Studio Making Dragon Quest XII
gameranx.com - May 1 at 9:01 AM
Square Enix’s Shift Toward Blockbusters Is Costing It $140 MillionSquare Enix’s Shift Toward Blockbusters Is Costing It $140 Million
inverse.com - May 1 at 2:01 AM
Square Enix Announces Over 22 Billion Yen in LossesSquare Enix Announces Over 22 Billion Yen in Losses
siliconera.com - April 30 at 9:00 PM
Square Enix Dealing With Heavy Losses By Being “Selective” About Future ProjectsSquare Enix Dealing With Heavy Losses By Being “Selective” About Future Projects
gameranx.com - April 30 at 9:00 PM
Square Enix cancels $140 million worth of games and projectsSquare Enix cancels $140 million worth of games and projects
tweaktown.com - April 30 at 9:00 PM
Speculation: Dragon Quest 3 HD-2Ds fate as Square Enix announces development changesSpeculation: Dragon Quest 3 HD-2D's fate as Square Enix announces development changes
msn.com - April 30 at 3:59 PM
Square Enix absorbs $140 million hit as canceled games take significant financial toll; company revising approach to HD titlesSquare Enix absorbs $140 million hit as canceled games take significant financial toll; company revising approach to HD titles
vg247.com - April 30 at 3:59 PM
Square Enix Will be "More Selective" With Spending Following Huge LossesSquare Enix Will be "More Selective" With Spending Following Huge Losses
comicbook.com - April 30 at 3:59 PM
Square Enix Is Rethinking How It Approaches Games, And Its Coming At A Huge CostSquare Enix Is Rethinking How It Approaches Games, And It's Coming At A Huge Cost
gamespot.com - April 30 at 3:59 PM
Square Enixs Financial Blow: $140M Loss From Game CancellationsSquare Enix's Financial Blow: $140M Loss From Game Cancellations
msn.com - April 30 at 3:59 PM
Final Fantasy Maker Square Enix Takes $140 Million Hit in ‘Content Abandonment Losses’ as It Revises Game PipelineFinal Fantasy Maker Square Enix Takes $140 Million Hit in ‘Content Abandonment Losses’ as It Revises Game Pipeline
msn.com - April 30 at 10:58 AM
Square Enix Declares $140m Loss Amid Game Pipeline ShakeupSquare Enix Declares $140m Loss Amid Game Pipeline Shakeup
techraptor.net - April 30 at 10:58 AM
Square-Enix Will Abandon More Than $100 Million in HD GamesSquare-Enix Will Abandon More Than $100 Million in HD Games
escapistmagazine.com - April 30 at 10:58 AM
Square Enix canceled $140 million-worth of games earlier this year as it looks to be "more selective"Square Enix canceled $140 million-worth of games earlier this year as it looks to be "more selective"
msn.com - April 30 at 10:58 AM
Square Enix takes $140 million hit on cancelled gamesSquare Enix takes $140 million hit on cancelled games
gamesindustry.biz - April 30 at 10:58 AM
Square Enix Holdings Co., Ltd. (OTCMKTS:SQNXF) Sees Significant Growth in Short InterestSquare Enix Holdings Co., Ltd. (OTCMKTS:SQNXF) Sees Significant Growth in Short Interest
americanbankingnews.com - April 30 at 4:38 AM
Square Enix Offering Special Gaming and Item Deals For Golden Week!Square Enix Offering Special Gaming and Item Deals For Golden Week!
gameranx.com - April 29 at 6:58 PM
Square Enix Golden Week Sale Discounts 29 Nintendo Switch Games (April 2024)Square Enix Golden Week Sale Discounts 29 Nintendo Switch Games (April 2024)
nintendo-insider.com - April 27 at 11:43 PM
Square Enix just released a premium AA JRPG on Android for $50Square Enix just released a premium AA JRPG on Android for $50
msn.com - April 26 at 10:38 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Arkema logo

Arkema

OTCMKTS:ARKAY
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. This segment also offers performance polymers, such as specialty polyamides, PVDF, polyimides, fluorospecialties, and polyetherketoneketone; and performance additives which includes molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide. The Advance Materials and Coating Solutions segment offers coating solutions, including comprising EU/US acrylics and coating resins; coating additives, such as sartomer photocure resins and coatex rheology additives. This segment also provides decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbent, water treatment and oil and gas extraction, and 3D printing and electronics industries. The Intermediates segment provides fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
Burberry Group logo

Burberry Group

OTCMKTS:BURBY
Burberry Group plc, together with its subsidiaries, manufactures, retails, and wholesales luxury goods under the Burberry brand. The company operates in two segments, Retail/Wholesale and Licensing. It provides womenswear, menswear, childrenswear, beauty, eyewear, shoes, and accessories, as well as leather goods, such as bags. The company also licenses third parties to manufacture and distribute products using the Burberry trademarks. It sells its products through Burberry mainline stores, concessions, outlets, digital commerce, Burberry franchisees, department stores, and multi-brand specialty accounts, as well as through Burberry.com website. It operates in the Asia Pacific, Europe, the Middle East, India, Africa, and the Americas. The company was founded in 1856 and is headquartered in London, the United Kingdom.
CapitaLand logo

CapitaLand

OTCMKTS:CLLDY
CapitaLand is one of Asia's largest real estate companies headquartered and listed in Singapore. The company leverages its significant asset base, design and development capabilities, active capital management strategies, and extensive market network and operational capabilities to develop high-quality real estate products and services. Its diversified global real estate portfolio includes integrated developments, shopping malls, serviced residences, offices and homes. The Group focuses on Singapore and China as our core markets, while it continues to expand in markets such as Vietnam and Indonesia. The company also has one of the largest real estate fund management businesses with assets located in Asia.
Hikma Pharmaceuticals logo

Hikma Pharmaceuticals

OTCMKTS:HKMPF
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Square Enix logo

Square Enix

OTCMKTS:SQNXF
Square Enix Holdings Co., Ltd. operates in the content and service businesses in Japan and internationally. It operates through Digital Entertainment Business, Amusement Business, Publishing Business, and Rights Property Business. The company plans, develops, sells, and manages digital entertainment content primarily in the form of computer games. It is also involved in the operation of amusement facilities; and planning, development, manufacture, sale, and rental of arcade game machines and related products for amusement facilities. In addition, the company publishes and licenses comic books, magazines, game-related books, periodicals, etc. Further, it plans, produces, distributes, and licenses secondary works; and offers content under the SQUARE ENIX PRODUCTS brand; and stuffed toys and utility goods under the SQEX TOYS brand. The company was incorporated in 1975 and is headquartered in Tokyo, Japan.